SEC Form 4 · accession 0001930732-26-000003
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Jin
Officer — Chief Financial Officer
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 9:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1,F2 | Jun 22, 2026 | A | 400,000 | $0.00 | A | 1,651,571 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents an award of 400,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments, with the first installment vesting on January 5, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Vested restricted stock units will be settled in shares of the Issuer's common stock.
- F2Total holdings include 1,230,000 shares underlying previously granted deferred restricted stock units.